Table 1.
DOL 28 | DOL 53 | DOL 83 (HD#4) | DOL 104 (HD#25) | DOL 154 (T +47) | Reference range | |
---|---|---|---|---|---|---|
Absolute Lymphocyte Count (/ul) | 977 | 1271 | 1510 | 2512 | 3920 | |
CD3+ % | 11.7 | 1.3 | 2.7 | 0.7 | 31.3 | 51−77% |
CD3+ abs (/ul) | 114 | 16 | 39 | 18 | 1300 | 2500−5800/ul |
CD3+4+ % | 1.2 | 0.4 | 1.1 | 0.4 | 27 | 35−58% |
CD3+4+ abs (/ul) | 12 | 5 | 15 | 9 | 1120 | 1800−4000/ul |
CD3+8+ % | 9.7 | 0.9 | 2.4 | 0.6 | 5.1 | 12−23% |
CD3+8+ abs (/ul) | 95 | 12 | 34 | 16 | 213 | 590−1600/ul |
CD16/56+ % | 5.5 | 2.3 | 0.3 | 0.5 | 12 | 3−14% |
CD16/56+ abs (/ul) | 54 | 29 | 4 | 13 | 497 | 170−830/ul |
CD19+ % | 78.8 | 95.1 | 94.6 | 95 | 51.3 | 11−41% |
CD19+ abs (/ul) | 770 | 1208 | 1340 | 2386 | 2133 | 430−3000/ul |
CD3+4+RA+62L+ % of tot CD4 | <0.1 | 33.3 | <0.1 | 64−92% | ||
CD3+8+RA+62l+ % of tot CD8 | 8.3 | 15 | <0.1 | 53−88% |